Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$424M |
| 2 |
Bath & Body Works
BBWI
|
+$342M |
| 3 |
Home Depot
HD
|
+$259M |
| 4 |
GE Aerospace
GE
|
+$247M |
| 5 |
Palo Alto Networks
PANW
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$917M |
| 2 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$396M |
| 3 |
Citigroup
C
|
+$377M |
| 4 |
Sherwin-Williams
SHW
|
+$292M |
| 5 |
Starbucks
SBUX
|
+$260M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.46% |
| 2 | Healthcare | 16.66% |
| 3 | Communication Services | 14.21% |
| 4 | Technology | 13.93% |
| 5 | Financials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Shake Shack
SHAK
$2.55B
| $16.1M | 0.02% |
431,644
-426,925
| -50% | -$15.4M |
|
427
CNX Resources
CNX
$4.91B
| $15.7M | 0.02% |
1,670,747
-392,775
| -19% | -$2.86M |
|
|
DWRE
428
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
| $15.6M | 0.02% |
398,450
+15,109
| +4% | +$587K |
|
429
PUT
iShares US Healthcare ETF
IYH
$3.44B
| $15.5M | 0.02% |
551,315
+411,675
| +295% | +$11.4M |
|
430
Renasant Corp
RNST
$4.01B
| $15.4M | 0.02% |
468,502
+29,047
| +7% | +$924K |
|
431
Insmed
INSM
$22.4B
| $14.9M | 0.02% |
1,177,504
+8,744
| +0.7% | +$115K |
|
|
BPL
432
DELISTED
Buckeye Partners, L.P.
BPL
| $14.8M | 0.02% |
218,533
+29,720
| +16% | +$1.82M |
|
|
CIM
433
Chimera Investment
CIM
$1.06B
| $14.8M | 0.02% |
362,083
+530
| +0.1% | +$20.6K |
|
434
Neurocrine Biosciences
NBIX
$18.3B
| $14.6M | 0.02% |
370,240
-124,367
| -25% | -$4.94M |
|
|
MPG
435
DELISTED
Metaldyne Performance Group Inc.
MPG
| $14.6M | 0.02% |
869,684
+74,501
| +9% | +$1.04M |
|
436
CALL
Incyte
INCY
$25.3B
| $14.5M | 0.02% |
+200,000
| New | +$14.9M |
|
437
Rocket Pharmaceuticals
RCKT
$341M
| $14.4M | 0.02% |
487,485
+7,522
| +2% | +$226K |
|
|
SAGE
438
DELISTED
Sage Therapeutics
SAGE
| $13.8M | 0.01% |
431,545
+176,400
| +69% | +$6.21M |
|
439
Freeport-McMoran
FCX
$86.5B
| $13.3M | 0.01% |
1,285,457
-325,472
| -20% | -$2.29M |
|
440
ProQR Therapeutics
PRQR
$248M
| $13.1M | 0.01% |
2,674,844
+1,673,070
| +167% | +$8.51M |
|
|
RDC
441
DELISTED
Rowan Companies Plc
RDC
| $13M | 0.01% |
805,655
-196,329
| -20% | -$2.72M |
|
442
Ocular Therapeutix
OCUL
$1.85B
| $12.8M | 0.01% |
1,329,345
+648,468
| +95% | +$4.91M |
|
|
OKS
443
DELISTED
Oneok Partners LP
OKS
| $12.8M | 0.01% |
407,978
+199,700
| +96% | +$5.63M |
|
|
TEP
444
DELISTED
Tallgrass Energy Partners, LP
TEP
| $12.8M | 0.01% |
333,140
+29,485
| +10% | +$1.03M |
|
445
HDFC Bank
HDB
$123B
| $12.7M | 0.01% |
827,304
-54,992
| -6% | -$786K |
|
|
KDNY
446
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $11.3M | 0.01% |
176,346
+5,278
| +3% | +$427K |
|
447
Match Group
MTCH
$9.24B
| $11M | 0.01% |
991,089
-38,722
| -4% | -$443K |
|
448
Kosmos Energy
KOS
$1.48B
| $10.9M | 0.01% |
1,881,077
-319,942
| -15% | -$1.51M |
|
|
DTEA
449
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $10.8M | 0.01% |
894,073
+13,394
| +2% | +$141K |
|
450
Brookfield Infrastructure Partners
BIP
$19.5B
| $10.8M | 0.01% |
646,131
+153,789
| +31% | +$2.23M |
|
Similar funds
Jennison Associates's Q1 2016 Portfolio in Review
As of Q1 2016, Jennison Associates held 710 positions worth $95.3B, down 6.5% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q1 2016 filing shows 56 new, 303 increased, 241 reduced and 102 closed positions. Its largest new stake was Procter & Gamble: 1,657,581 shares worth $136M. The largest sale was LinkedIn Corporation, an estimated $917M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.
- Jennison Associates's largest Q1 2016 buy was Procter & Gamble: 1,657,581 shares worth $136M.
- Jennison Associates added most to Microsoft in Q1 2016, an estimated $424M increase.
- Jennison Associates's biggest Q1 2016 reduction was LinkedIn Corporation, cutting an estimated $917M.
- Jennison Associates fully exited Sherwin-Williams in Q1 2016, selling an estimated $292M.
- Jennison Associates's ten largest holdings make up 24% of its $95.3B portfolio in Q1 2016.
- Jennison Associates opened 56 new positions and closed 102 in Q1 2016.
- Jennison Associates's portfolio value fell 6.5% quarter-over-quarter to $95.3B.
Based on Jennison Associates's 13F filing for Q1 2016, filed 3 May 2016.